Evaluate
the effects of treatment at various stages and develop additional treatment plans, if required
Not exact matches
But researchers
at the University
of Aberdeen found that a
treatment originally designed for fighting cancer and diabetes could melt away fatty arterial plaque with a single dosing and reverse the
effects of atherosclerosis, which can lead to multiple heart problems.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount
of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in
treatment duration; availability
of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction
of generic versions
of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the
effect of lowering prices or reducing the number
of insured patients; the possibility
of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels
of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits
of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or
at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages
of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development
of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate
of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Many laboratory tests were performed and chemotherapy — requiring intravenous punctures — was resumed, even though studies had shown that this type
of cancer does not respond significantly, if
at all, to drug
treatment, and even though complications and side
effects from the drugs were expected.
An
at - home exfoliating
treatment is a great way to ensure your skin is ready to soak up the hydrating
effects of coconut oil.
Patients
at the Comprehensive Cancer Center donated their sore mouths, and the result was what the Yale Alumni Magazine described as «a hot new
treatment for debilitating side
effects of cancer
treatment.»
This was before Mackey had won a single Iditarod, let alone four straight; before he used what he calls his marathon style — catnapping as his sled moves and covering 100 - mile chunks
at a moderate pace without prolonged rest, instead
of sprinting from rest stop to rest stop like most other racers — to win an unprecedented double (the Yukon Quest, the world's other 1,000 - mile dogsled race, and just weeks later the Iditarod) not once but twice; before he became so dominant that slower competitors complained they had no chance to finish within five days
of him (the requirement for an official place and a commemorative belt buckle); and before a rival pushed for drug testing
at the 2010 Iditarod, suspecting that Mackey's secret was his prescription for medical marijuana to alleviate the side
effects of cancer
treatment.
And
at this year's conference, sessions included «Avoiding Unnecessary Guilt When Breast - Feeding Does Not Happen,» «Medications & Mother's Milk,» «The
Effect of Media Violence on Children» and «Complementary
Treatments to Postpartum Depression.»
For cessation
of exclusive breastfeeding
at up to four to six weeks there appears to be differential
treatment effect according to the number
of support contacts, with four to eight contacts the most effective schedule.
For cessation
of any breastfeeding
at up to six months it appeared that support from non-professionals was associated with a broadly similar
treatment effect to that for support from professionals (Analysis 2.1).
However, we noted that the introduction
of nonbreastfeeding
at 1 y, when the children were 15 mo old, was a significant main
effect of the D
treatment because 4 women who had not received the D
treatment were still providing breastfeeding with complementary foods.
However there was some evidence that more pronounced
treatment effects were associated with studies
at higher risk
of bias; this could potentially confound any differences between subgroups.
Believing the old word
of mouth that having dental
treatment during pregnancy can have adverse
effects on the health
of your baby, is exactly what will put you and your baby
at risk.
We attempted to examine this by assessing the intensity
of the intervention, and we found studies with four to eight visits to be associated with a more pronounced
treatment effect on exclusive breastfeeding
at final study assessment.
Again, there was some evidence that the
treatment effect may be partly due to bias; sensitivity analysis including only those studies assessed as being
at low risk
of bias for allocation concealment showed that results still favoured the intervention group although the
treatment effect was less pronounced in the studies
at lower risk
of bias (Analysis 1.8).
For cessation
of exclusive breastfeeding
at up to six months the
treatment effect appears to be greater when the intervention was delivered by non-professionals (lay support) compared with professionals or mixed support (test for subgroup differences: Chi ² = 7.74, df = 2 (P = 0.02), I ² = 73.1 %; Analysis 2.2).
The President, who was speaking
at the inauguration
of the Lavender Hill feacal
treatment plant, was also optimistic
of a reduction in negative health
effects associated with poor liquid waste disposal and management in the short to medium term.
Researchers looked
at the
effect of a 3 - day
treatment of tetracycline, a commonly used antibiotic, on the amount
of methane generated within the manure
of cattle.
Treatment with zoledronic acid was associated with a 73 percent and a 65 percent reduction in bone loss relative to placebo
at 12 weeks and 24 weeks respectively, an
effect that lasted throughout the 48 weeks
of the study.
«A significant body
of research has resulted in a shift from thinking
of placebos as just «dummy»
treatments to recognizing that placebo
effects encompass numerous aspects
of the health care experience and are central to medicine and patient care,» said the article's coauthor Ted Kaptchuk, Director
of the Program in Placebo Studies
at Beth Israel Deaconess Medical Center (BIDMC) and Professor
of Medicine
at Harvard Medical School.
For men with intermediate risk prostate cancer, side
effects at two years following radiation therapy (RT) were comparable for extremely - hypofractionated
treatment, which was delivered in seven fractions across two and a half weeks, and conventional
treatment of 39 fractions across eight weeks, according to research presented
at the 58th Annual Meeting
of the American Society for Radiation Oncology (ASTRO).
Immunotherapy doubles overall survival and improves quality
of life, with fewer side
effects, in a
treatment - resistant and rapidly progressing form
of head and neck carcinoma, reports a large, randomized international trial co-led by investigators
at the University
of Pittsburgh Cancer Institute (UPCI).
At most centers,
treatment for inflammatory bowel disease (IBD) is limited and usually takes patients down one
of two routes: steroids or medication, which can often lead to life - long side
effects.
«Our preclinical data suggest that combining low doses
of these inhibitors will enhance the clinical
effects of both drugs as a potential
treatment for patients with AML,» says the senior author, Feyruz V. Rassool, PhD, associate professor
of radiation oncology
at the University
of Maryland School
of Medicine (UM SOM) and a researcher
at the University
of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center (UMGCCC).
«Interestingly, we also found that vitamin C
treatment had an
effect on leukemic stem cells that resembled damage to their DNA,» says first study author Luisa Cimmino, PhD, an assistant professor in the Department
of Pathology
at NYU Langone Health.
«This
treatment is a new form
of cell transplantation that utilizes the patient's own cells, so it does not require immunosuppressive drugs and, thus, avoids the side
effects of those drugs,» says Scott Nyberg, M.D., Ph.D., a liver transplant surgeon
at Mayo Clinic.
Even when Unger adjusted his model to account for the fact that not all patients may get the new
treatment, and even when he lowered the
effect of the new
treatment to three, not five years, the model showed a benefit
of at least 2 million years in nearly every simulation.
Researchers
at New York Eye and Ear Infirmary
of Mount Sinai showed that a microdose delivery system achieved a
treatment effect comparable to a conventional eyedropper, while delivering less than four times the amount
of drug.
«Our research has led to the development
of a test that can detect patients that will benefit from
treatment up front and spare those who are
at lower risk from the side -
effects of chemotherapy.
«Most researchers have relied on cell lines to screen the
effect of drugs and other
treatments including viruses,» said Dr. Cripe, who also is a professor
at The Ohio State University College
of Medicine.
Furthermore, older patients are
at risk from the adverse side -
effects of adjuvant
treatments such as hormone therapy or chemotherapy.
Instead, researchers told the European Breast Cancer Conference that their findings suggest that extending screening programs to older women results in a large proportion
of women being over-treated, and
at risk from the harmful
effects of such
treatment, because these women were more likely to die from other causes than from any tumors detected in the early stages
of growth.
At this stage, the aims
of the trials would be modest, seeking only to assess whether the
treatments have a measurable
effect, rather than expecting dramatic clinical improvement
of the patients» condition.
Further scientific investigation is warranted to determine how the drug achieves its
effects as well as how they might be used in the
treatment of «the ennui and anguish
of impending death» as well as «alcoholism and other forms
of drug addiction,» argues Charles Schuster, a neuroscientist
at Wayne State University and a former director
of the National Institute on Drug Abuse, in a commentary on the paper.
«The advantage
of being able to deliver methotrexate in this targeted way is to be able to gain the benefits from this key
treatment of RA, while reducing the risk
of adverse
effects that are more frequent
at high doses,» concluded Dr Macor.
Researchers
at the University
of Sheffield have developed a novel implantable material which could reduce the number
of debilitating side -
effects that occur as a result
of using a material that is too rigid for surgical
treatment of incontinence.
New findings by a biomedical engineer and his team
at the University
of Houston (UH) raise hope for a new class
of drugs to treat lupus that may not include the long list
of adverse risks and side
effects often associated with current
treatments for this disease.
«Since several BACE1 inhibitors are currently being evaluated in clinical phase 3 trials for the
treatment of Alzheimer's disease, the identification
of potential side
effects will be
of great importance to ensure a positive clinical outcome,» said Dr. Jochen Herms, a Professor
of translational brain research
at Ludwig - Maximilians - University Munich.
A team
of researchers
at the University
of Georgia has developed a non-invasive method
of delivering drugs directly to cancerous tissue using magnetic forces, a form
of treatment that could significantly reduce the toxic side
effects of chemotherapy.
«Our collaboration with scientists
at Charles Gerhardt Institute was important to the success
of this two - photon activated technique,» said Tamanoi, «which provides controls over drug delivery to allow local
treatment that dramatically reduces side
effects.»
This review looked
at the
effects of adding antimicrobial drugs to this
treatment.
Even
at this stage, measuring the number
of innate lymphoid cells in the blood makes it possible to provide a prognosis
of the
effects of treatment.
The paper, written by authors
at King's College London and Baylor College
of Medicine, reviews contraceptive devices available including those already used by military and aviation personnel, and calls for more research into the
effect of hormone
treatments on bone mineral loss in space.
The
effect of hormone
treatments on bone mineral density (BMD) is another issue for spaceflight, where astronauts lose bone
at a much higher rate than on Earth.
This enabled us to examine whether the possible
effects of rapamycin depend on the age
at which
treatment started.»
(A placebo is a «sugar pill» or «dummy»
treatment that is given in research studies to compare
effects of an actual
treatment compared to no
treatment at all).
The large study looked
at the
effects of antihypertensive
treatment on the risk
of dementia over a period
of up to 24 years in 1262 older African Americans with high blood pressure who were cognitively normal
at the onset
of the study.
The diagnosis and
treatment of female cancers are known to affect fertility for several reasons: some chemotherapy regimens can cause damage to the ovary, and this can occur
at any age; radiotherapy can also compromise female fertility through
effects on the ovary, uterus and potentially those brain centres which control the reproductive axis.
The researchers believe that their software has the potential to help doctors to identify which
of those patients are
at low risk
of suffering side
effects and hence might benefit from
treatment.
However, this study indicates that not all
at risk patients show accelerated lung function decline, which may explain why, so far, the
effect of various
treatments of lung function decline has been difficult to establish.